FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
8,216 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Meropenem | Meropenem 500 mg/20mL | InjectionIntravenous | Sandoz Inc | ANDA | 0781-3000 | 00781-3000-9500781-3000-96 | — |
| Meropenem | Meropenem 1 g/30mL | InjectionIntravenous | Sandoz Inc | ANDA | 0781-3098 | 00781-3098-9500781-3098-96 | — |
| Meropenem | Meropenem 500 mg/20mL | Injection, Powder, For solutionIntravenous | Sagent Pharmaceuticals | ANDA | 25021-160 | 25021-0160-20 | — |
| Meropenem | Meropenem 1 g/30mL | Injection, Powder, For solutionIntravenous | Sagent Pharmaceuticals | ANDA | 25021-161 |
| 25021-0161-30 |
| — |
| Meropenem | Meropenem 500 mg/1 | Injection, Powder, For solutionIntravenous | WG Critical Care, LLC | ANDA | 44567-145 | 44567-0145-10 | — |
|---|
| Meropenem | Meropenem 1 g/1 | Injection, Powder, For solutionIntravenous | WG Critical Care, LLC | ANDA | 44567-146 | 44567-0146-10 | — |
|---|
| Meropenem | Meropenem 500 mg/1 | Injection, Powder, For solutionIntravenous | WG Critical Care, LLC | ANDA | 44567-400 | 44567-0400-10 | — |
|---|
| Meropenem | Meropenem 1 g/1 | Injection, Powder, For solutionIntravenous | WG Critical Care, LLC | ANDA | 44567-401 | 44567-0401-10 | — |
|---|
| Meropenem | Meropenem 2 g/1 | Injection, Powder, For solutionIntravenous | WG Critical Care, LLC | NDA | 44567-402 | 44567-0402-06 | — |
|---|
| Meropenem | Meropenem 500 mg/20mL | InjectionIntravenous | Savior Lifetec Corporation | ANDA | 44647-032 | 44647-0032-10 | — |
|---|
| Meropenem | Meropenem 1 g/30mL | InjectionIntravenous | Savior Lifetec Corporation | ANDA | 44647-033 | 44647-0033-10 | — |
|---|
| Meropenem | Meropenem 500 mg/20mL | InjectionIntravenous | Qilu Antibiotics Pharmaceutical Co., Ltd. | ANDA | 51810-502 | 51810-0502-02 | — |
|---|
| Meropenem | Meropenem 1 g/30mL | InjectionIntravenous | Qilu Antibiotics Pharmaceutical Co., Ltd. | ANDA | 51810-503 | 51810-0503-02 | — |
|---|
| Meropenem | Meropenem 500 mg/1 | Injection, Powder, For solutionIntravenous | Eugia US LLC | ANDA | 55150-207 | 55150-0207-20 | — |
|---|
| Meropenem | Meropenem 1 g/1 | Injection, Powder, For solutionIntravenous | Eugia US LLC | ANDA | 55150-208 | 55150-0208-30 | — |
|---|
| Meropenem | Meropenem 500 mg/10mL | Injection, Powder, For solutionIntravenous | Fresenius Kabi USA, LLC | ANDA | 63323-507 | 63323-0507-20 | — |
|---|
| Meropenem | Meropenem 1 g/20mL | Injection, Powder, For solutionIntravenous | Fresenius Kabi USA, LLC | ANDA | 63323-508 | 63323-0508-31 | — |
|---|
| Meropenem | Meropenem 500 mg/20mL | Injection, Powder, For solutionIntravenous | BluePoint Laboratories | ANDA | 68001-323 | — | — |
|---|
| Meropenem | Meropenem 1 g/30mL | Injection, Powder, For solutionIntravenous | BluePoint Laboratories | ANDA | 68001-324 | — | — |
|---|
| Meropenem | Meropenem 500 mg/20mL | InjectionIntravenous | Gland Pharma Limited | ANDA | 68083-146 | 68083-0146-10 | — |
|---|
| Meropenem | Meropenem 1 g/30mL | InjectionIntravenous | Gland Pharma Limited | ANDA | 68083-147 | 68083-0147-10 | — |
|---|
| Meropenem | Meropenem 1 g/30mL | Injection, Powder, For solutionIntravenous | Amneal Pharmaceuticals LLC | ANDA | 70121-1453 | 70121-1453-07 | — |
|---|
| Meropenem | Meropenem 500 mg/20mL | Injection, Powder, For solutionIntravenous | Amneal Pharmaceuticals LLC | ANDA | 70121-1454 | 70121-1454-07 | — |
|---|
| Meropenem | Meropenem 500 mg/1 | Injection, Powder, For solutionIntravenous | Xellia Pharmaceuticals USA LLC | ANDA | 70594-075 | 70594-0075-02 | — |
|---|
| Meropenem | Meropenem 1 g/1 | Injection, Powder, For solutionIntravenous | Xellia Pharmaceuticals USA LLC | ANDA | 70594-076 | 70594-0076-02 | — |
|---|
| Meropenem | Meropenem anhydrous 2 g/1 | InjectionIntravenous | Mylan Institutional LLC | ANDA | 72078-081 | 72078-0081-06 | — |
|---|
| Meropenem | Meropenem 500 mg/20mL | InjectionIntravenous | ARMAS PHARMACEUTICALS INC | ANDA | 72485-411 | 72485-0411-0172485-0411-1072485-0411-25 | — |
|---|
| Meropenem | Meropenem 1 g/20mL | InjectionIntravenous | ARMAS PHARMACEUTICALS INC | ANDA | 72485-412 | 72485-0412-0172485-0412-1072485-0412-25 | — |
|---|
| Meropenem | Meropenem 1 g/20mL | InjectionIntravenous | Civica, Inc. | ANDA | 72572-410 | 72572-0410-10 | — |
|---|
| Meropenem | Meropenem 500 mg/20mL | InjectionIntravenous | Civica, Inc. | ANDA | 72572-412 | 72572-0412-10 | — |
|---|
| Meropenem | Meropenem 500 mg/20mL | InjectionIntravenous | Civica, Inc | ANDA | 72572-415 | 72572-0415-10 | — |
|---|
| Meropenem | Meropenem 1 g/30mL | InjectionIntravenous | Civica, Inc | ANDA | 72572-416 | 72572-0416-10 | — |
|---|
| Meropenem | Meropenem 500 mg/20mL | InjectionIntravenous | BROOKS STERISCIENCE LIMITED | ANDA | 81962-000 | 81962-0000-0181962-0000-0281962-0000-03 | — |
|---|
| Meropenem | Meropenem 1 g/20mL | InjectionIntravenous | BROOKS STERISCIENCE LIMITED | ANDA | 81962-001 | 81962-0001-0181962-0001-0281962-0001-03 | — |
|---|
| Meropenem | Meropenem anhydrous 2 g/1 | InjectionIntravenous | BROOKS STERISCIENCE LIMITED | ANDA | 81962-002 | 81962-0002-08 | — |
|---|
| Meropenem and Sodium Chloride | Meropenem 500 mg/50mL | Injection, SolutionIntravenous | B. Braun Medical Inc. | NDA | 0264-3183 | 00264-3183-11 | — |
|---|
| Meropenem and Sodium Chloride | Meropenem 1 g/50mL | Injection, SolutionIntravenous | B. Braun Medical Inc. | NDA | 0264-3185 | 00264-3185-11 | — |
|---|
| Merthiolatebenzalkonium chloride | Benzalkonium chloride 1.3 mg/mL | LiquidTopical | Pharma Nobis, LLC | OTC monograph drug | 82645-912 | 82645-0912-92 | — |
|---|
| Merthiolate Tincture First Aid Antisepticbenzalkonium chloride 0.13% | Benzalkonium chloride 1.3 mg/mL | LiquidTopical | Germa Products, LLC | OTC monograph drug | 73635-1224 | 73635-1224-01 | — |
|---|
| Mesalamine | Mesalamine 400 mg/1 | Capsule, Delayed releaseOral | Teva Pharmaceuticals USA, Inc. | ANDA | 0093-5907 | 00093-5907-86 | — |
|---|
| mesalamine | Mesalamine 375 mg/1 | Capsule, Extended releaseOral | Teva Pharmaceuticals USA, Inc. | NDA authorized generic | 0093-9224 | 00093-9224-89 | — |
|---|
| Mesalamine | Mesalamine .375 g/1 | Capsule, Extended releaseOral | Mylan Pharmaceuticals Inc. | ANDA | 0378-1375 | 00378-1375-78 | — |
|---|
| Mesalamine | Mesalamine 1000 mg/1 | SuppositoryRectal | Actavis Pharma, Inc. | ANDA | 0472-1915 | 00472-1915-30 | — |
|---|
| Mesalamine | Mesalamine 800 mg/1 | Tablet, Delayed releaseOral | Teva Pharmaceuticals, Inc. | ANDA | 0480-7750 | 00480-7750-80 | — |
|---|
| Mesalamine | Mesalamine 1.2 g/1 | Tablet, Delayed releaseOral | Lannett Company Inc. | ANDA | 0527-3012 | 00527-3012-48 | — |
|---|
| Mesalamine | Mesalamine 1.2 g/1 | Tablet, Delayed releaseOral | Actavis Pharma, Inc. | ANDA | 0591-2245 | 00591-2245-22 | — |
|---|
| Mesalamine | Mesalamine 250 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | ANDA | 0781-2791 | 00781-2791-64 | — |
|---|
| Mesalamine | Mesalamine 500 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | ANDA | 0781-2793 | 00781-2793-72 | — |
|---|
| Mesalamine | Mesalamine .375 g/1 | Capsule, Extended releaseOral | Upsher-Smith Laboratories, LLC | ANDA | 0832-6056 | 00832-6056-12 | — |
|---|
| mesalamine | Mesalamine 1.2 g/1 | Tablet, Delayed releaseOral | Major Pharmaceuticals | ANDA | 0904-6832 | 00904-6832-04 | — |
|---|